Kadimastem Ltd (KDST) - Net Assets

Latest as of June 2025: ILA-50.85 Million ILA

Based on the latest financial reports, Kadimastem Ltd (KDST) has net assets worth ILA-50.85 Million ILA as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA1.55 Million) and total liabilities (ILA52.41 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric	Value
Current Net Assets	ILA-50.85 Million
% of Total Assets	-3272.39%
Annual Growth Rate	N/A
5-Year Change	N/A
10-Year Change	N/A
Growth Volatility	503.81

Kadimastem Ltd - Net Assets Trend (2010–2024)

This chart illustrates how Kadimastem Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Kadimastem Ltd (2010–2024)

The table below shows the annual net assets of Kadimastem Ltd from 2010 to 2024.

Year	Net Assets	Change
2024-12-31	ILA-29.15 Million	-568.49%
2023-12-31	ILA-4.36 Million	-1437.42%
2022-12-31	ILA326.00K	-97.88%
2021-12-31	ILA15.38 Million	+290.80%
2020-12-31	ILA-8.06 Million	+32.96%
2019-12-31	ILA-12.03 Million	-278.48%
2018-12-31	ILA6.74 Million	+57.43%
2017-12-31	ILA4.28 Million	+150.02%
2016-12-31	ILA-8.56 Million	-736.36%
2015-12-31	ILA-1.02 Million	-166.13%
2014-12-31	ILA1.55 Million	-78.74%
2013-12-31	ILA7.28 Million	+207.36%
2012-12-31	ILA-6.78 Million	-95.44%
2011-12-31	ILA-3.47 Million	-77.25%
2010-12-31	ILA-1.96 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Kadimastem Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 23220800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Other Components	ILA245.07 Million	%
Total Equity	ILA-29.15 Million	100.00%

Kadimastem Ltd Competitors by Market Cap

The table below lists competitors of Kadimastem Ltd ranked by their market capitalization.

Company	Market Cap
Starr Peak Exploration Ltd V:STE	$22.18 Million
Hammerson PLC LSE:HMSO	$22.19 Million
Invoicery Group AB ST:FRILAN	$22.19 Million
Wing Yip Food (China) Holdings Group Limited KQ:900340	$22.20 Million
exax Inc KQ:060230	$22.17 Million
Secuve Co. Ltd KQ:131090	$22.16 Million
SOLWERS OYJ EO 1 F:0ST	$22.16 Million
Eden Innovations Ltd AU:EDE	$22.16 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Kadimastem Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from -4,360,000 to -29,146,000, a change of -24,786,000.
Net loss of 26,552,000 reduced equity.
Other factors increased equity by 1,766,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	ILA-26.55 Million	-91.1%
Other Changes	ILA1.77 Million	+6.06%
Total Change	ILA-	%

Book Value vs Market Value Analysis

This analysis compares Kadimastem Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2017-12-31	ILA0.75	ILA2794.00	x
2018-12-31	ILA0.71	ILA2794.00	x
2019-12-31	ILA-1.17	ILA2794.00	x
2020-12-31	ILA-0.41	ILA2794.00	x
2021-12-31	ILA0.46	ILA2794.00	x
2022-12-31	ILA0.01	ILA2794.00	x
2023-12-31	ILA-1.04	ILA2794.00	x
2024-12-31	ILA-6.95	ILA2794.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Kadimastem Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 0.00%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 0.00%
• Asset Turnover: 0.00x
• Equity Multiplier: 0.00x
Recent ROE (0.00%) is above the historical average (-762.60%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2013	-173.39%	-5255.83%	0.02x	1.71x	ILA-13.34 Million
2014	-981.97%	-4703.10%	0.03x	7.77x	ILA-15.35 Million
2015	0.00%	-1659.92%	0.13x	0.00x	ILA-16.96 Million
2016	0.00%	-1172.81%	0.36x	0.00x	ILA-19.12 Million
2017	-500.65%	-3132.75%	0.06x	2.83x	ILA-21.86 Million
2018	-355.71%	0.00%	0.00x	2.17x	ILA-24.64 Million
2019	0.00%	0.00%	0.00x	0.00x	ILA-23.88 Million
2020	0.00%	0.00%	0.00x	0.00x	ILA-20.90 Million
2021	-170.82%	0.00%	0.00x	1.78x	ILA-27.81 Million
2022	-6968.71%	0.00%	0.00x	38.31x	ILA-22.75 Million
2023	0.00%	0.00%	0.00x	0.00x	ILA-11.57 Million
2024	0.00%	0.00%	0.00x	0.00x	ILA-23.64 Million

Industry Comparison

This section compares Kadimastem Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $57,334,206
Average return on equity (ROE) among peers: -16.09%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Kadimastem Ltd (KDST)	ILA-50.85 Million	-173.39%	N/A	$22.18 Million
BioLine RX Ltd (BLRX)	$31.77 Million	-32.03%	0.14x	$9.10 Million
BioLight Life Sciences Ltd (BOLT)	$2.72 Million	0.00%	2.72x	$6.28 Million
Bonus Biogroup (BONS)	$-13.72 Million	0.00%	0.00x	$123.37 Million
Can Fite Biopharma Ltd (CANF)	$2.07 Million	0.00%	0.31x	$5.34 Million
Clal Biotechnology Industries Ltd (CBI)	$309.49 Million	-14.40%	0.36x	$14.38 Million
DNA Biomed Solns (DNA)	$10.45 Million	0.00%	0.61x	$34.27 Million
G.F.C Green Fields Capital Ltd. (GFC-M)	$134.15 Million	1.81%	0.56x	$40.23 Million
Matricelf Ltd (MTLF)	$35.79 Million	-34.88%	0.10x	$23.73 Million
Plantarc Bio Ltd (PLNT)	$3.29 Million	-65.33%	0.19x	$1.96 Million

About Kadimastem Ltd

TA:KDST Israel Biotechnology

Market Cap

$22.18 Million

ILA8.27 Billion ILA

Market Cap Rank

#27680 Global

#368 in Israel

Share Price

ILA2794.00

Change (1 day)

-1.13%

52-Week Range

ILA2082.00 - ILA3680.00

All Time High

ILA78228.15